FDA approves Promacta for use in patients with serious blood disorder

FDA has approved the once-daily use of eltrombopag (Promacta, GlaxoSmithKline) in patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
» Read about this new indication for Promacta

Collaborative care improves depression in teens

Teens who received the collaborative care intervention in primary care had significantly greater improvements in depressive symptoms than teens who were receiving treatment as usual, according to a study published in JAMA.
» Read about antidepressant use in this population

Continuing Education

MTM essentials for atrial fibrillation and drug-induced arrhythmia management

This month's article is the seventh in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review current clinical practice guidelines related to atrial fibrillation.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exam and earn up to 2 CPE credits, click here to log in with the session code 14DT09-ZXT88.

Announcement: Starting this month, our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

Prescription at discharge linked to long-term adherence to stroke meds

Stroke patients are 70% more likely to continue taking their stroke prevention medications 1 year later if they are given a prescription when discharged, and 40% more likely after 2 years, according a study published in the Journal of Stroke and Cerebrovascular Diseases. » Full article

• The latest FDA drug approvals

• [INFOGRAPHIC]: E-cigarette use tied to smoking in teens

RESOURCES

Latest Clinical News